CVS HEALTH Corp·4

Feb 3, 4:32 PM ET

PELUSO MICHELLE A 4

4 · CVS HEALTH Corp · Filed Feb 3, 2023

Insider Transaction Report

Form 4
Period: 2023-02-02
PELUSO MICHELLE A
EVP and Co-President of Retail
Transactions
  • Award

    Common Stock

    2023-02-02+192,554207,465 total
Holdings
  • Common Stock (restricted)

    82,563
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (86,386 underlying)
    86,386
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (57,172 underlying)
    57,172
Footnotes (4)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 26, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 2, 2023.
  • [F2]Consists of Restricted Stock Unit awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 02/26/2022.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2022.
  • [F4]Option becomes exercisable in four equal annual installments, commencing 4/1/2023.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT